Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01296087 · ClinicalTrials.gov registry record · Phase 2
TC-6987 for the Treatment of Mild to Moderate Asthma
A Phase 2 study of Asthma, sponsored by Targacept.
- Completed
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
- 20
- Study locations
NCT01296087: Completed Phase 2 study of Asthma, sponsored by Targacept.
NCT01296087 is a Phase 2 study of Asthma that has completed, run by Targacept. The registered enrollment target is 203 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01296087, a Phase 2 study of Asthma, has completed, sponsored by Targacept.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is designed to determine whether TC-6987 improves respiratory function in subjects with asthma by reducing airway hyper-responsiveness and inflammation.
Primary Outcome
Co-primary efficacy endpoints: 1. the change in FEV1 from pre dose on Day 1 to pre dose on Day 28 2. the change in FEV1 from pre dose on Day 1 to 2 h post dose on Day 28
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TC-6987
Study Locations (20)
Florida
- Avail Clinical Research LLC - DeLand
- Sarasota Clinical Research - Sarasota
- Florida Pulmonary Research Institute, Inc. - Winter Park
California
- California Allergy and Asthma Medical Group, Inc. - Los Angeles
- California Allergy & Asthma Medical Group - Palmdale
Pennsylvania
- Altoona Lung Specialists - Altoona
- Allergy & Asthma Research of New Jersey, Inc. - Philadelphia
Texas
- Pioneer Research Solutions - Houston
- Paragon Research - San Antonio
Alabama
- Clinical research Center of Alabama - Birmingham
Arizona
- Medical Research of Arizona - Scottsdale
Connecticut
- Waterbury Pulmonary Associates - Waterbury
North Carolina
- Allergy Partners of Western North Carolina - Asheville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT01296087 record still lists
NCT01296087 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01296087 names 20 study sites across 15 states, led by Florida, California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01296087 about?
NCT01296087 is a clinical study titled "TC-6987 for the Treatment of Mild to Moderate Asthma". This study is designed to determine whether TC-6987 improves respiratory function in subjects with asthma by reducing airway hyper-responsiveness and inflammation.
What is the current status of trial NCT01296087?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 203 participants. The study started on 2011-02. Estimated completion is 2012-01.
What conditions does trial NCT01296087 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT01296087?
The interventions under investigation include: Placebo (DRUG), TC-6987 (DRUG).
Who is sponsoring clinical trial NCT01296087?
This trial is sponsored by Targacept, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01296087 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01296087's enrollment target sits among peer trials
203 159th of 374 higher than 215 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05652686 · 203 participants · Phase 1
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- NCT06063122 · 203 participants · NA
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
- NCT07031245 · 203 participants · NA
Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia